The American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic & Bariatric Surgery (ASMBS) have issued a new white paper on the potential role of endoscopic bariatric therapies (EBTs) in treating obesity and obesity-related diseases like Type 2 diabetes.The real criteria for success are can they sell it and turn a profit.
The white paper entitled, "A Pathway to Endoscopic Bariatric Therapies," appears online in both GIE: Gastrointestinal Endoscopy, the peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE) and Surgery for Obesity and Related Diseases (SOARD), the peer-reviewed scientific journal of the American Society for Metabolic & Bariatric Surgery (ASMBS).
"The two societies formed a joint task force to identify opportunities where endoscopic treatments may play a role in improving patient outcomes and reducing costs," said Gregory G. Ginsberg, MD, FASGE, ASGE president and chair of the ASGE/ASMBS Task Force on EBT. "The white paper establishes the criteria for success as new technologies and procedures are developed."
Friday, December 02, 2011
Exploring The Role Of Endoscopy In Treating Obesity
Another way for the sick care system to make a buck off fatsos.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment